{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:14:22Z","timestamp":1790367262355,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Lundbeck Otsuka Alliance"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-06725-3","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T09:09:42Z","timestamp":1744880982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Assessment of functional recovery in patients with schizophrenia, with a focus on early-phase disease: results from a Delphi consensus and narrative review"],"prefix":"10.1186","volume":"25","author":[{"given":"Philip","family":"Gorwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Madera-McDonough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Fagiolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Arc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Barlassina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhani","family":"Selveindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Sahota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"9","key":"6725_CR1","first-page":"638","volume":"39","author":"KR Patel","year":"2014","unstructured":"Patel KR, Cherian J, Gohil K, Atkinson D. Schizophrenia: overview and treatment options. P T. 2014;39(9):638\u201345.","journal-title":"P T"},{"issue":"2","key":"6725_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/bmjspcare-2021-002936","volume":"12","author":"Z Hoseinipalangi","year":"2022","unstructured":"Hoseinipalangi Z, Golmohammadi Z, Rafiei S, Pashazadeh Kan F, Hosseinifard H, Rezaei S, Ahmadi S, Ahmadi N, Raoofi S, Aghajani F, et al. Global health-related quality of life in schizophrenia: systematic review and meta-analysis. BMJ Support Palliat Care. 2022;12(2):123\u201331.","journal-title":"BMJ Support Palliat Care"},{"issue":"1","key":"6725_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12888-018-1755-2","volume":"18","author":"G Lahera","year":"2018","unstructured":"Lahera G, G\u00e1lvez JL, S\u00e1nchez P, Mart\u00ednez-Roig M, P\u00e9rez-Fuster J, Garc\u00eda-Portilla P, Herrera B, Roca M. Functional recovery in patients with schizophrenia: recommendations from a panel of experts. BMC Psychiatry. 2018;18(1):176.","journal-title":"BMC Psychiatry"},{"issue":"12","key":"6725_CR4","doi-asserted-by":"publisher","first-page":"B16","DOI":"10.1016\/j.clinthera.2011.11.016","volume":"33","author":"CU Correll","year":"2011","unstructured":"Correll CU, Kishimoto T, Nielsen J, Kane JM. Quantifying clinical relevance in the treatment of schizophrenia. Clin Ther. 2011;33(12):B16\u201339.","journal-title":"Clin Ther"},{"issue":"4","key":"6725_CR5","first-page":"252","volume":"48","author":"MA Silva","year":"2019","unstructured":"Silva MA, Restrepo D. Functional recovery in schizophrenia. Rev Colomb Psiquiatr (Engl Ed). 2019;48(4):252\u201360.","journal-title":"Rev Colomb Psiquiatr (Engl Ed)"},{"issue":"3","key":"6725_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/schbul\/sbj044","volume":"32","author":"AS Bellack","year":"2006","unstructured":"Bellack AS. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr Bull. 2006;32(3):432\u201342.","journal-title":"Schizophr Bull"},{"issue":"2","key":"6725_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/schbul\/sbn186","volume":"35","author":"PD Harvey","year":"2009","unstructured":"Harvey PD. Functional recovery in schizophrenia: raising the bar for outcomes in people with schizophrenia. Schizophr Bull. 2009;35(2):299.","journal-title":"Schizophr Bull"},{"issue":"3","key":"6725_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/j.2051-5545.2012.tb00118.x","volume":"11","author":"RP Liberman","year":"2012","unstructured":"Liberman RP. Recovery from schizophrenia: form follows functioning. World Psychiatry. 2012;11(3):161\u20132.","journal-title":"World Psychiatry"},{"issue":"1","key":"6725_CR9","first-page":"4","volume":"10","author":"B Crespo-Facorro","year":"2017","unstructured":"Crespo-Facorro B, Bernardo M, Argimon JM, Arrojo M, Bravo-Ortiz MF, Cabrera-Cifuentes A, Carretero-Roman J, Franco-Martin MA, Garcia-Portilla P, Haro JM. Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: rethinking project. Rev Psiquiatr Salud Ment (English Edition). 2017;10(1):4\u201320.","journal-title":"Rev Psiquiatr Salud Ment (English Edition)"},{"issue":"5","key":"6725_CR10","first-page":"42345","volume":"83","author":"CU Correll","year":"2022","unstructured":"Correll CU, Ismail Z, McIntyre RS, Rafeyan R, Thase ME. Patient functioning, life engagement, and treatment goals in schizophrenia. J Clin Psychiatry. 2022;83(5):42345.","journal-title":"J Clin Psychiatry"},{"key":"6725_CR11","doi-asserted-by":"crossref","unstructured":"Correll CU, Ismail Z, McIntyre RS, Rafeyan R, Thase ME: Patient functioning and life engagement: unmet needs in major depressive disorder and schizophrenia. J Clin Psychiatry 2022, 83(4):LU21112AH21111.","DOI":"10.4088\/JCP.LU21112AH1"},{"issue":"2","key":"6725_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/schbul\/sbac103","volume":"49","author":"HG Hansen","year":"2023","unstructured":"Hansen HG, Speyer H, Starzer M, Albert N, Hjorth\u00f8j C, Eplov LF, Nordentoft M. Clinical recovery among individuals with a first-episode schizophrenia an updated systematic review and meta-analysis. Schizophr Bull. 2023;49(2):297\u2013308.","journal-title":"Schizophr Bull"},{"issue":"3","key":"6725_CR13","first-page":"97","volume":"44","author":"M Roca","year":"2016","unstructured":"Roca M. Is it possible to achieve functional recovery in schizophrenia? A qualitative and quantitative analysis of psychiatrist\u2019s opinion. Actas Esp Psiquiatr. 2016;44(3):97\u2013106.","journal-title":"Actas Esp Psiquiatr"},{"issue":"1","key":"6725_CR14","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2023.12","volume":"66","author":"E Scanferla","year":"2023","unstructured":"Scanferla E, de Bienassis K, Pachoud B, Gorwood P. How subjective well-being, patient-reported clinical improvement (PROMs) and experience of care (PREMs) relate in an acute psychiatric care setting? Eur Psychiatry. 2023;66(1): e26.","journal-title":"Eur Psychiatry"},{"issue":"1","key":"6725_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-023-04928-0","volume":"23","author":"C Arango","year":"2023","unstructured":"Arango C, Fagiolini A, Gorwood P, Kane JM, Diaz-Mendoza S, Sahota N, Correll CU. Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery. BMC Psychiatry. 2023;23(1):1\u201311.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"6725_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/schbul\/sbac046","volume":"48","author":"YH Lin","year":"2022","unstructured":"Lin YH, Wu CS, Liu CC, Kuo PH, Chan HY, Chen WJ. Comparative effectiveness of antipsychotics in preventing readmission for first-admission schizophrenia patients in national cohorts from 2001 to 2017 in Taiwan. Schizophr Bull. 2022;48(4):785\u201394.","journal-title":"Schizophr Bull"},{"issue":"6","key":"6725_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/0004867419837358","volume":"53","author":"AT Olagunju","year":"2019","unstructured":"Olagunju AT, Clark SR, Baune BT. Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome. Aust N Z J Psychiatry. 2019;53(6):509\u201327.","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"6725_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1287\/mnsc.9.3.458","volume":"9","author":"N Dalkey","year":"1963","unstructured":"Dalkey N, Helmer O. An experimental application of the Delphi method to the use of experts. Manage Sci. 1963;9(3):458\u201367.","journal-title":"Manage Sci"},{"issue":"9","key":"6725_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2105\/AJPH.74.9.979","volume":"74","author":"A Fink","year":"1984","unstructured":"Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health. 1984;74(9):979\u201383.","journal-title":"Am J Public Health"},{"key":"6725_CR20","doi-asserted-by":"crossref","unstructured":"Rowe G, Wright G: Expert opinions in forecasting: the role of the Delphi technique. In: Principles of forecasting: a handbook for researchers and practitioners. edn. Edited by Armstrong JS; 2001: 125\u2013144.","DOI":"10.1007\/978-0-306-47630-3_7"},{"issue":"3","key":"6725_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/schbul\/sbv185","volume":"42","author":"DI Velligan","year":"2016","unstructured":"Velligan DI, Mintz J, Sierra C, Martin ML, Fredrick M, Maglinte GA, Corey-Lisle PK. The Daily Activity Report (DAR) a novel measure of functional outcome for serious mental illness. Schizophr Bull. 2016;42(3):579\u201387.","journal-title":"Schizophr Bull"},{"issue":"2\u20133","key":"6725_CR22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.schres.2009.04.029","volume":"113","author":"P-M Llorca","year":"2009","unstructured":"Llorca P-M, Lan\u00e7on C, Lancrenon S, Bayle F-J, Caci H, Rouillon F, Gorwood P. The \u201cFunctional Remission of General Schizophrenia\u201d(FROGS) scale: development and validation of a new questionnaire. Schizophr Res. 2009;113(2\u20133):218\u201325.","journal-title":"Schizophr Res"},{"issue":"11","key":"6725_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/NMD.0b013e3181f97bf9","volume":"198","author":"I Gonzalez-Ortega","year":"2010","unstructured":"Gonzalez-Ortega I, Rosa A, Alberich S, Barbeito S, Vega P, Echeburua E, Vieta E, Gonzalez-Pinto A. Validation and use of the functioning assessment short test in first psychotic episodes. J Nerv Ment Dis. 2010;198(11):836\u201340.","journal-title":"J Nerv Ment Dis"},{"key":"6725_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1744-859X-10-2","volume":"10","author":"IM Aas","year":"2011","unstructured":"Aas IM. Guidelines for rating Global Assessment of Functioning (GAF). Ann Gen Psychiatry. 2011;10:2.","journal-title":"Ann Gen Psychiatry"},{"issue":"6","key":"6725_CR25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","volume":"33","author":"J Endicott","year":"1976","unstructured":"Endicott J, Spitzer RL, Fleiss JL, Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33(6):766\u201371.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"6725_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.rehab.2013.11.005","volume":"57","author":"C Belio","year":"2014","unstructured":"Belio C, Prouteau A, Koleck M, Saada Y, Merceron K, Dayre E, Destaillats JM, Barral C, Mazaux JM. Participation restrictions in patients with psychiatric and\/or cognitive disabilities: preliminary results for an ICF-derived assessment tool. Ann Phys Rehabil Med. 2014;57(2):114\u201337.","journal-title":"Ann Phys Rehabil Med"},{"issue":"1","key":"6725_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12955-017-0701-1","volume":"15","author":"W Smith","year":"2017","unstructured":"Smith W, Vitoratou S, McCrone P, Patel A. Exploring the factor structure of the Health of the Nation Outcomes Scale (HoNOS) in a sample of patients with schizophrenia, schizotypal and delusional disorders. Health Qual Life Outcomes. 2017;15(1):141.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"6725_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","volume":"10","author":"DW Heinrichs","year":"1984","unstructured":"Heinrichs DW, Hanlon TE, Carpenter WTJ. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984;10(3):388\u201398.","journal-title":"Schizophr Bull"},{"issue":"9","key":"6725_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4276\/030802212X13470263980793","volume":"75","author":"L Haglund","year":"2012","unstructured":"Haglund L, F\u00e4ltman S. Activity and Participation \u2014 self-assessment according to the International Classification of Functioning: a study in mental health. Br J Occup Ther. 2012;75(9):412\u20138.","journal-title":"Br J Occup Ther"},{"key":"6725_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.eurpsy.2017.09.001","volume":"47","author":"J Mallet","year":"2018","unstructured":"Mallet J, Lancrenon S, Llorca P-M, Lan\u00e7on C, Bayl\u00e9 F-J, Gorwood P. Validation of a four items version of the Functional Remission of General Schizophrenia scale (the mini-FROGS) to capture the functional benefits of clinical remission. Eur Psychiatry. 2018;47:35\u201341.","journal-title":"Eur Psychiatry"},{"key":"6725_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13033-015-0030-x","volume":"9","author":"F Pinna","year":"2015","unstructured":"Pinna F, Fiorillo A, Tusconi M, Guiso B, Carpiniello B. Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy. Int J Ment Health Syst. 2015;9:37.","journal-title":"Int J Ment Health Syst"},{"issue":"6","key":"6725_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.comppsych.2007.05.017","volume":"48","author":"TS Ehmann","year":"2007","unstructured":"Ehmann TS, Goldman R, Yager J, Xu Y, MacEwan GW. Self-reported cognitive and everyday functioning in persons with psychosis: the Patient Perception of Functioning Scale. Compr Psychiatry. 2007;48(6):597\u2013604.","journal-title":"Compr Psychiatry"},{"issue":"4","key":"6725_CR33","first-page":"323","volume":"101","author":"PL Morosini","year":"2000","unstructured":"Morosini PL, Magliano L. Brambilla La, Ugolini S, Pioli R: Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning. Acta Psychiatr Scand. 2000;101(4):323\u20139.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"6725_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eurpsy.2010.12.012","volume":"27","author":"Y Barak","year":"2012","unstructured":"Barak Y, Swartz M. Remission amongst elderly schizophrenia patients. Eur Psychiatry. 2012;27(1):62\u20134.","journal-title":"Eur Psychiatry"},{"issue":"1","key":"6725_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpsy.2017.08.002","volume":"32","author":"L De Pinho","year":"2018","unstructured":"De Pinho L, Pereira A, Chaves C, Batista P. Quality of Life Scale and symptomatology of schizophrenic patients\u2013a systematic review. Eur J Psychiatry. 2018;32(1):1\u201310.","journal-title":"Eur J Psychiatry"},{"issue":"1\u20133","key":"6725_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.schres.2010.05.019","volume":"121","author":"L Boyer","year":"2010","unstructured":"Boyer L, Simeoni MC, Loundou A, D\u2019Amato T, Reine G, Lancon C, Auquier P. The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia. Schizophr Res. 2010;121(1\u20133):241\u201350.","journal-title":"Schizophr Res"},{"issue":"1\u20132","key":"6725_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0920-9964(02)00355-9","volume":"63","author":"P Auquier","year":"2003","unstructured":"Auquier P, Simeoni MC, Sapin C, Reine G, Aghababian V, Cramer J, Lancon C. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr Res. 2003;63(1\u20132):137\u201349.","journal-title":"Schizophr Res"},{"key":"6725_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1192\/bjp.177.1.42","volume":"177","author":"G Wilkinson","year":"2000","unstructured":"Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, Fitzpatrick R, Jenkinson C. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry. 2000;177:42\u20136.","journal-title":"Br J Psychiatry"},{"issue":"2\u20133","key":"6725_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.schres.2008.10.002","volume":"107","author":"L Kleinman","year":"2009","unstructured":"Kleinman L, Lieberman J, Dube S, Mohs R, Zhao Y, Kinon B, Carpenter W, Harvey PD, Green MF, Keefe RS, et al. Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function. Schizophr Res. 2009;107(2\u20133):275\u201385.","journal-title":"Schizophr Res"},{"issue":"1","key":"6725_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/YIC.0000000000000240","volume":"34","author":"YJ Zhao","year":"2019","unstructured":"Zhao YJ, He YL, Zhang LL, Qiao Y, Zhao JP, Si TM, Wang G, Zhang N, Ning YP, Zhang MY. The reliability and validity of a newly developed self-rating functional scale compared with Personal and Social Performance Scale and World Health Organization Disability Assessment Schedule II. Int Clin Psychopharmacol. 2019;34(1):37\u201344.","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"6725_CR41","first-page":"11","volume":"25","author":"J Giner","year":"1997","unstructured":"Giner J, Ib\u00e1\u00f1ez E, Baca E, Bobes J, Leal C, Cervera S. Desarrollo del cuestionario Sevilla de Calidad de Vida (CSCV). Actas Luso-Esp Neurol Psiquiatr. 1997;25(2):11\u201323.","journal-title":"Actas Luso-Esp Neurol Psiquiatr"},{"key":"6725_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.psychres.2019.03.037","volume":"276","author":"EHC Chan","year":"2019","unstructured":"Chan EHC, Kong SDX, Park SH, Song YJC, Demetriou EA, Pepper KL, Glozier N, Hickie IB, Guastella AJ. Validation of the social functioning scale: Comparison and evaluation in early psychosis, autism spectrum disorder and social anxiety disorder. Psychiatry Res. 2019;276:45\u201355.","journal-title":"Psychiatry Res"},{"key":"6725_CR43","doi-asserted-by":"crossref","unstructured":"Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S: The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 1990, 157:853\u2013859.","DOI":"10.1192\/bjp.157.6.853"},{"issue":"1","key":"6725_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11136-007-9288-z","volume":"17","author":"AK Kawata","year":"2008","unstructured":"Kawata AK, Revicki DA. Reliability and validity of the social integration survey (SIS) in patients with schizophrenia. Qual Life Res. 2008;17(1):123\u201335.","journal-title":"Qual Life Res"},{"issue":"3","key":"6725_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/00048674.2010.545984","volume":"45","author":"S Vothknecht","year":"2011","unstructured":"Vothknecht S, Schoevers RA, de Haan L. Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review. Aust N Z J Psychiatry. 2011;45(3):182\u201392.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"6725_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.31887\/DCNS.2006.8.1\/wmillas","volume":"8","author":"W de Millas","year":"2006","unstructured":"de Millas W, Lambert M, Naber D. The impact of subjective well-being under neuroleptic treatment on compliance and remission. Dialogues Clin Neurosci. 2006;8(1):131\u20136.","journal-title":"Dialogues Clin Neurosci"},{"issue":"9","key":"6725_CR47","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/j.1440-1614.2004.01448.x","volume":"38","author":"PK Chopra","year":"2004","unstructured":"Chopra PK, Couper JW, Herrman H. The assessment of patients with long-term psychotic disorders: application of the WHO Disability Assessment Schedule II. Aust N Z J Psychiatry. 2004;38(9):753\u20139.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"6725_CR48","doi-asserted-by":"publisher","first-page":"14005","DOI":"10.1038\/npjschz.2014.5","volume":"1","author":"CM D\u00edaz-Caneja","year":"2015","unstructured":"D\u00edaz-Caneja CM, Pina-Camacho L, Rodr\u00edguez-Quiroga A, Fraguas D, Parellada M, Arango C. Predictors of outcome in early-onset psychosis: a systematic review. NPJ Schizophr. 2015;1(1):14005.","journal-title":"NPJ Schizophr"},{"key":"6725_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/7854_2010_40","volume":"4","author":"E Bromley","year":"2010","unstructured":"Bromley E, Brekke JS. Assessing function and functional outcome in schizophrenia. Curr Top Behav Neurosci. 2010;4:3\u201321.","journal-title":"Curr Top Behav Neurosci"},{"issue":"12","key":"6725_CR50","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1176\/appi.ajp.21121189","volume":"179","author":"M Solmi","year":"2022","unstructured":"Solmi M, Taipale H, Holm M, Tanskanen A, Mittendorfer-Rutz E, Correll CU, Tiihonen J. Effectiveness of antipsychotic use for reducing risk of work disability: results from a within-subject analysis of a Swedish national cohort of 21,551 patients with first-episode nonaffective psychosis. Am J Psychiatry. 2022;179(12):938\u201346.","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"6725_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.schres.2007.04.033","volume":"94","author":"X Fan","year":"2007","unstructured":"Fan X, Henderson DC, Chiang E, Briggs LB, Freudenreich O, Evins AE, Cather C, Goff DC. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophr Res. 2007;94(1\u20133):119\u201327.","journal-title":"Schizophr Res"},{"issue":"6","key":"6725_CR52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/s-0044-100627","volume":"51","author":"T Dembler-Stamm","year":"2018","unstructured":"Dembler-Stamm T, Fiebig J, Heinz A, Gallinat J. Sexual dysfunction in unmedicated patients with schizophrenia and in healthy controls. Pharmacopsychiatry. 2018;51(6):251\u20136.","journal-title":"Pharmacopsychiatry"},{"key":"6725_CR53","doi-asserted-by":"crossref","unstructured":"Qaderi K, Yazdkhasti M, Zangeneh S, Behbahani BM, Kalhor M, Shamsabadi A, Jesmani Y, Norouzi S, Kajbafvala M, Khodavirdilou R et al: Changes in sexual activities, function, and satisfaction during the COVID-19 pandemic era: a systematic review and meta-analysis. Sex Med 2023, 11(2):qfad005.","DOI":"10.1093\/sexmed\/qfad005"},{"issue":"8","key":"6725_CR54","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jsxm.2020.03.005","volume":"17","author":"S Zhao","year":"2020","unstructured":"Zhao S, Wang X, Qiang X, Wang H, He J, Shen M, Zheng C, Kang R. Is there an association between schizophrenia and sexual dysfunction in both sexes? A systematic review and meta-analysis. J Sex Med. 2020;17(8):1476\u201388.","journal-title":"J Sex Med"},{"issue":"7","key":"6725_CR55","doi-asserted-by":"publisher","first-page":"924","DOI":"10.4088\/JCP.14m09128","volume":"76","author":"G Fervaha","year":"2015","unstructured":"Fervaha G, Takeuchi H, Agid O, Lee J, Foussias G, Remington G. Determinants of patient-rated and clinician-rated illness severity in schizophrenia. J Clin Psychiatry. 2015;76(7):924\u201330.","journal-title":"J Clin Psychiatry"},{"issue":"suppl 3","key":"6725_CR56","doi-asserted-by":"publisher","first-page":"21984","DOI":"10.4088\/JCP.15032su1","volume":"77","author":"CU Correll","year":"2016","unstructured":"Correll CU, Citrome L, Haddad PM, Lauriello J, Olfson M, Calloway SM, Kane JM. The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence. J Clin Psychiatry. 2016;77(suppl 3):21984.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"6725_CR57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1192\/apt.bp.114.013565","volume":"21","author":"P Bosanac","year":"2015","unstructured":"Bosanac P, Castle DJ. Why are long-acting injectable antipsychotics still underused? BJPsych Advances. 2015;21(2):98\u2013105.","journal-title":"BJPsych Advances"},{"issue":"8","key":"6725_CR58","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/14656566.2016.1174692","volume":"17","author":"L Hargarter","year":"2016","unstructured":"Hargarter L, Bergmans P, Cherubin P, Keim S, Conca A, Serrano-Blanco A, Bitter I, Bilanakis N, Schreiner A. Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia. Expert Opin Pharmacother. 2016;17(8):1043\u201353.","journal-title":"Expert Opin Pharmacother"},{"key":"6725_CR59","doi-asserted-by":"crossref","unstructured":"Kim S, Kim S, Koh M, Choi G, Kim J-J, Paik I-H, Kim S-H, Choi Y-S, Lee Y, Suh J: Effects of long-acting injectable paliperidone palmitate on clinical and functional outcomes in patients with schizophrenia based on illness duration. J Clin Psychiatry 2021, 82(1):20m13446.","DOI":"10.4088\/JCP.20m13446"},{"issue":"8","key":"6725_CR60","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1017\/S0033291720003335","volume":"52","author":"KH Nuechterlein","year":"2022","unstructured":"Nuechterlein KH, Ventura J, Subotnik KL, Gretchen-Doorly D, Turner LR, Casaus LR, Luo J, Boucher ML, Hayata JN, Bell MD. A randomized controlled trial of cognitive remediation and long-acting injectable risperidone after a first episode of schizophrenia: improving cognition and work\/school functioning. Psychol Med. 2022;52(8):1517\u201326.","journal-title":"Psychol Med"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06725-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06725-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06725-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:04:36Z","timestamp":1744884276000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06725-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6725"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06725-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"13 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the Delphi panel study was sought from Pearl Pathways (reference: #23-OHTH-106, 30\/1\/2023), a central Institutional Review Board that reviewed and approved all study material including the protocol. Given the fact that no individual patient data was collected in the course of this study and physician participation was voluntary, this study was determined to be Exempt according to the FDA 21 CFR 56.104 and 45CFR46.104(d)(2). The study was conducted in accordance with the relevant guidelines and regulations for research involving human subjects. Information on study purpose, format, and outputs were provided to the panelists through a market research agreement document. Informed consent was obtained from all panelists before their participation in this Delphi panel.The narrative review was based on previously conducted studies, and ethical approval was therefore deemed not necessary.This study was conducted in accordance with the principles of the Declaration of Helsinki, ensuring ethical standards in research involving human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"P.G. received fees during the last 5\u00a0years for presentations at congresses or participation in scientific boards from Angelini, EISI, Janssen, Lundbeck, Otsuka, Richter, Merck, and Viatris. M.Y. is a full-time employee of H. Lundbeck A\/S. J. M. is a full-time employee of Otsuka Pharmaceutical Development and Commercialization Inc. A. F. is\/has been a consultant and\/or a speaker and\/or has received research grants from Angelini, Apsen, Boehringer Ingelheim, Daiichi Sankyo, GlaxoSmithKline, Italfarmaco, Lundbeck, Janssen, Mylan, Otsuka, Pfizer, Recordati, Sanofi Aventis, Sunovion, Viatris, and Vifor. C.A. has received support by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (ISCIII), co-financed by the European Union, ERDF Funds from the European Commission, \u201cA way of making Europe,\u201d financed by the European Union \u2013 NextGenerationEU (PMP21\/00051), PI19\/01024. CIBERSAM, Madrid Regional Government (B2017\/BMD-3740 AGES-CM-2), European Union Structural Funds, European Union Seventh Framework Program, European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking: Project PRISM-2 (Grant agreement No.101034377), Project AIMS-2-TRIALS (Grant agreement No 777394), Horizon Europe, the National Institute of Mental Health of the National Institutes of Health under Award Number 1U01MH124639-01 (Project ProNET) and Award Number 5P50MH115846-03 (project FEP-CAUSAL), Fundaci\u00f3n Familia Alonso, and Fundaci\u00f3n Alicia Koplowitz. C.A. additionally has been a consultant to or has received honoraria or grants from Acadia, Angelini, Biogen, Boehringer, Gedeon Richter, Janssen Cilag, Lundbeck, Medscape, Menarini, Minerva, Otsuka, Pfizer, Roche, Sage, Servier, Shire, Schering-Plough, Sumitomo Dainippon Pharma, Sunovion, and Takeda. C.U.C. has been a consultant and\/or advisor to or has received honoraria from: AbbVie, Acadia, Adcock Ingram, Alkermes, Allergan, Angelini, Aristo, Biogen, Boehringer-Ingelheim, Bristol Myers Squibb, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Delpor, Denovo, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Jamjoom Pharma, Janssen\/J&J, Karuna, LB Pharma, Lundbeck, MedInCell, Merck, Mindpax, Mitsubishi Tanabe Pharma, Maplight, Mylan, Neumora Therapeutics, Neurocrine, Neurelis, Newron, Noven, Novo Nordisk, Otsuka, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Sage, Saladax, Seqirus, SK Life Science, Sumitomo Pharma America, Sunovion, Sun Pharma, Supernus, Tabuk, Takeda, Teva, Tolmar, Vertex, Viatris and Xenon Pharmaceuticals. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways, Denovo, Lundbeck, Relmada, Reviva, Rovi, Supernus, and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Kuleon Biosciences, LB Pharma, Mindpax, and Quantic. J.M.K. has been a consultant for or received honoraria from Alkermes, Allergan, Boehringer Ingelheim, Cerevel, Dainippon Sumitomo, H. Lundbeck, HealthRhythms, HLS, Indivior, Intracellular Therapies, Janssen Pharmaceutical, Johnson & Johnson, LB Pharmaceuticals, Merck, Minerva, Neurocrine, Newron, Novartis, Otsuka, Roche, Saladax, Sunovion, and Teva. Dr. Kane has received grant support from Otsuka, Lundbeck, Sunovion and Janssen. Dr. Kane is a shareholder in Vanguard Research Group, North Shore Therapeutics, Health Rhythms, MedinCell, and LB Pharmaceuticals, Inc. N.S. is a former employee of OPEN Health, which received funding from Lundbeck Otsuka Alliance to conduct this study. E.A., A.B., and S.S. are employees of OPEN Health, which received funding from Lundbeck Otsuka Alliance to conduct this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"398"}}